VistaGen Working on Oral Ketamine-like Compound for Depression

Two US patents will help deliver ketamine-like antidepressant effects, says VistaGen

A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift

Pharma giants are looking to ketamine for clues to the next blockbuster depression drug — and science says they're onto something big

The K factor: How the party drug ketamine may hold the key to treating patients with severe depression

Street Gets More Bullish On Allergan As It Sees Solid Growth Ahead